LEADER 01709nam  2200349 n 450 
001 9910688490103321
005 20250808225323.0
035   $a(CKB)5400000000045416
035   $a(NjHacI)995400000000045416
035   $a(EXLCZ)995400000000045416
100   $a20230626d2020      uy         0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aDrug Repurposing $eHypothesis, Molecular Aspects and Therapeutic Applications /$fedited by Farid A. Badria
210  1$aLondon, England :$cIntechOpen,$d2020.
215   $a1 online resource (234 pages)
311 08$a1-83968-522-0 
330   $aDrug repurposing or drug repositioning is a new approach to presenting new indications for common commercial and clinically approved existing drugs. For example, chloroquine, an old antimalarial drug, showed promising results for treating COVID-19, interfering with MDR in several types of cancer, and chemosensitizing human leukemic cells.This book focuses on the hypothesis, risk/benefits, and economic impacts of drug repurposing on drug discovery in dermatology, infectious diseases, neurological disorders, cancer, and orphan diseases. It brings together up-to-date research to provide readers with an informative, illustrative, and easy-to-read book useful for students, clinicians, and the pharmaceutical industry.
517   $aDrug Repurposing
606   $aDrug development
615  0$aDrug development.
676   $a615.19
702   $aBadria$b Farid A.
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688490103321
996   $aDrug Repurposing$92954022
997   $aUNINA